Tech Company Financing Transactions

GlycoFi Funding Round

On 12/10/2003, GlycoFi raised $10 million in Series C funding from Fletcher Spaght Ventures, Borealis Ventures and Boston Millennia Partners.

Transaction Overview

Company Name
Announced On
12/10/2003
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series C
Proceeds Purpose
The funding will be used to expand the company's development of second-generation biopharmaceuticals and to make key hires in the business and preclinical development areas.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
21 Lafayette St. 200
Lebanon, NH 03766
USA
Email Address
Not Recorded
Overview
GlycoFi, Inc. is the industry leader for the engineering and production of therapeutic glycoproteins in yeast systems.
Profile
GlycoFi LinkedIn Company Profile
Social Media
GlycoFi Company Twitter Account
Company News
GlycoFi News
Facebook
GlycoFi on Facebook
YouTube
GlycoFi on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Charles Hutchinson
  Charles Hutchinson LinkedIn Profile  Charles Hutchinson Twitter Account  Charles Hutchinson News  Charles Hutchinson on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/9/2003: Red Bend Software venture capital transaction
Next: 12/12/2003: Xanthus Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. All VC database entries on this site are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary